By proceeding, you agree to our Terms of Use and Privacy Policy.
The Only Global RAS Dedicated Conference is Returning in 2022 with the 3rd RAS/MAPK Pathway Targeted Drug Discovery Summit! Year on year, we are proud to unite the leading frontiers of the RAS industry to showcase expertise, technical data and pipeline updates, all geared toward accelerating the discovery and development of anti-RAS therapies.
Biotech experts will discuss ways to successfully drug RAS driven cancers, advanced screening and tools and identification of target escape routes.
Gain exclusive insights on the potent and second gen RAS targeted therapies to successfully drug all RAS driven cancers in lung and beyond.
Interaction with experts will inspire you to harness RAS mutations, giving you the opportunity to establish and accelerate your drug discovery platform.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Founded in 2013, Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development.
Helping patients fight treatment resistant cancer. Resistance Bio can discover and overcome clinical treatment resistance pre-clinically.
At Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.